Pacific Edge leads NZ shares higher

Pacific Edge leads NZ shares higher
Kaiser gave the green light to add Cxbladder to its electronic medical records system. (Image: Pacific Edge)
Dan Brunskill
New Zealand's main share index rose on Wednesday after Pacific Edge announced a US healthcare provider would now be able to order its cancer test more quickly and easily.The S&P/NZX 50 Index rose 64.89 points, or 0.6%, to 11,373.24. Turnover was $137 million.Pacific Edge led the market higher, jumping almost 17% to 83 cents, after it announced healthcare giant Kaiser Permanente had given the green light to add Cxbladder to its electronic medical records system.While it may sound technical, this project has been under way for months and...

More Markets

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price
Markets

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price

Cancer diagnostics company Pacific Edge has announced that the United States' Centers for Medicare & Medicaid Services (CMS) recommended a final “gapfill” price for its Cxbladder Triage Plus.CMS is proposing a price of US$1,328.32 (NZ$2,241.71), which is about 30% higher than...

Briscoe's bottom line squeezed despite flat first-half sales
Retail

Briscoe's bottom line squeezed despite flat first-half sales

Rod Duke expects full-year profits to come in lower than previously signalled.

ANZ's NZ operation may escape worst of 'Nuno-geddon'
Finance

ANZ's NZ operation may escape worst of 'Nuno-geddon'

ANZ NZ’s performance might be its potential saving grace.

NZX 50 stumbles as Ebos losses mount
Markets Market Close

NZX 50 stumbles as Ebos losses mount

The NZX 50 has erased Monday's gains. 

Gregor Thompson 09 Sep 2025